Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Yu Shen
Professor
Biostatistics
https://orcid.org/0000-0002-3899-7868
h-index
12076
Citations
56
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
1996 …
2024
Research activity per year
Overview
Fingerprint
Network
Research output
(234)
Similar Profiles
(7)
Fingerprint
Dive into the research topics where Yu Shen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Breast Neoplasms
100%
Survival
48%
Neoplasms
44%
Breast
39%
Inflammatory Breast Neoplasms
37%
Drug Therapy
25%
Early Detection of Cancer
24%
Urinary Bladder Neoplasms
19%
Radiotherapy
19%
Recurrence
17%
Therapeutics
17%
Databases
17%
Prophylactic Mastectomy
16%
Acute Myeloid Leukemia
16%
Confidence Intervals
16%
Cancer Survivors
14%
Neoadjuvant Therapy
14%
Trastuzumab
14%
Costs and Cost Analysis
14%
GATA2 Deficiency
13%
Mastectomy
13%
Mammography
12%
Estrogen Receptors
12%
Clinical Trials
12%
Myelodysplastic Syndromes
12%
Sample Size
12%
Segmental Mastectomy
11%
Carcinoma
11%
Proportional Hazards Models
11%
Hormones
11%
Cost-Benefit Analysis
11%
Guidelines
11%
Cohort Studies
10%
Population
10%
Patient Reported Outcome Measures
9%
Biomarkers
9%
Survival Analysis
8%
Neoplasm Metastasis
8%
Carcinoma, Intraductal, Noninfiltrating
8%
Disease-Free Survival
8%
Cisplatin
8%
Statistics
8%
Prostatic Neoplasms
8%
Biopsy
8%
Medicare
7%
Quality-Adjusted Life Years
7%
gemcitabine
7%
Comorbidity
7%
Incidence
6%
Mathematics
Biased
28%
Cancer
27%
Biased Sampling
26%
Breast Cancer
25%
Screening
21%
Covariates
20%
Clinical Trials
16%
Semiparametric Model
14%
Dementia
14%
Survival Data
13%
Estimator
13%
Simulation Study
11%
Adaptive Design
11%
Censored Survival Data
10%
Cohort Study
10%
Test Statistic
10%
Accelerated Failure Time Model
10%
Modeling
9%
Failure Time Data
9%
Estimating Equation
9%
Sample Size
9%
Cox Model
9%
Baseline
9%
Design
9%
Treatment Effects
9%
Survival Time
8%
Failure Time
8%
Monitoring
8%
Costs
8%
Hazard Function
8%
Right-censored Data
8%
Estimate
7%
Risk Factors
7%
Semiparametric Estimation
7%
Trajectory
7%
Performance
7%
Likelihood
7%
Epidemiology
7%
Evaluate
7%
Additive Risk Model
7%
Early Termination
6%
Semiparametric Regression
6%
Sample Size Re-estimation
6%
Competing Risks
6%
Estrogen Receptor
6%
Survival Distribution
6%
Weight Function
6%
Model
6%
Sojourn Time
6%
Surveillance
6%